(Q33862466)

29 July 2017

title

'Elderly' patients with newly diagnosed glioblastoma deserve optimal care (English)

1 reference

29 July 2017

1 reference

Matthias Holdhoff

1

1 reference

29 July 2017

Gary L Rosner

series ordinal

2

1 reference

29 July 2017

Sara Alcorn

series ordinal

3

1 reference

29 July 2017

Stuart A Grossman

series ordinal

4

1 reference

29 July 2017

publication date

23 March 2013

1 reference

Journal of Neuro-Oncology

29 July 2017

published in

1 reference

29 July 2017

volume

113

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

343-344

1 reference

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086527

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086527

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086527

Treatment of glioblastoma in "elderly" patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086527

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086527

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086527

10.1007/S11060-013-1113-7

5 July 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference